1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Vietnam Pharmaceuticals and Healthcare Report Q4 2016

Vietnam Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 112 pages

Includes 3 FREE quarterly updates

BMI View:

Ongoing regulatory reform and the relaxation of the 49% cap on foreign ownership will continue to increase the appeal of Vietnamese pharmaceutical equities to foreign investors. This trend will reflect the government efforts to attract foreign investment in order to develop the pharmaceutical sector as well as foreign companies aim to gain a competitive edge in the domestic market. However, due to public procurement bias towards local producers, the rise of domestic pharmaceutical companies will also present competitive threats to multinational drugmakers operating in the country, eventually leading to variations in their business models.


Headline Expenditure Projections

- Pharmaceuticals: VND92.5trn (USD4.2bn) in 2015 to VND105.6trn (USD4.7bn) in 2016; +14.2% in local currency terms and +11.7% in US dollar terms. Forecast in line in local currency terms and revised slightly upwards in US dollar terms compared to the last quarter.

- Healthcare: VND304.5trn (USD13.9bn) in 2015 to VND333.6bn (USD14.9bn) in 2016; +9.6% in local currency terms and +7.2% in US dollar terms. Forecast revised slightly upwards compared to the last quarter.

Table Of Contents

Vietnam Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Vietnam 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 26
Generic Drug Market Forecast 27
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 29
OTC Medicine Market Forecast 30
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 32
Pharmaceutical Trade Forecast 33
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2014-2020) 35
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2014-2020) 35
Pharmaceuticals and Healthcare Risk/Reward Index 36
Asia Pacific Risk/Reward Index - Q4 2016 36
Vietnam Risk/Reward Index 43
Rewards 43
Risks 44
Regulatory Review 45
Intellectual Property Issues 50
Table: Special 301 Submission: Issues Raised For Vietnam 51
Pricing Regime 54
Reimbursement Regime 59
Market Overview 61
Healthcare Sector 62
Table: Healthcare Resources (Vietnam 2010-2015) 65
Table: Healthcare Personnel (Vietnam 2010-2015) 65
Table: Healthcare Activity (Vietnam 2010-2015) 66
Research and Development 71
Competitive Landscape 81
Vietnam Pharmaceuticals and Healthcare Report Q4 2016$$
Research-Based Industry 81
Table: Multinational Market Activity 85
Pharmaceutical Distribution 86
Pharmaceutical Retail Sector 86
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries 88
Company Profile 89
DHG Pharmaceutical 89
GlaxoSmithKline 91
Sanofi 93
Traphaco Pharmaceutical 96
Vietnam Pharmaceutical Corporation (Vinapharm) 98
Demographic Forecast 101
Table: Population Headline Indicators (Vietnam 1990-2025) 102
Table: Key Population Ratios (Vietnam 1990-2025) 102
Table: Urban/Rural Population and Life Expectancy (Vietnam 1990-2025) 103
Table: Population By Age Group (Vietnam 1990-2025) 103
Table: Population By Age Group % (Vietnam 1990-2025) 104
Glossary 106
Methodology 108
Pharmaceutical Expenditure Forecast Model 108
Healthcare Expenditure Forecast Model 108
Notes On Methodology 109
Risk/Reward Index Methodology 110
Index Overview 111
Table: Pharmaceutical Risk/Reward Index Indicators 111
Indicator Weightings 112

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.